Prior to vaccine availability, RSV was a significant cause of illness and hospitalization in older adults in the U.S., ...

Older adults' immune systems naturally weaken with age, making them more susceptible to COVID-19, influenza (flu) and RSV. Here's what you need to know about these respiratory viruses and why ...

It is sending invites out to this group aged 75 to 80 warning that RSV poses a threat all year round. RSV causes a common ...

The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study.

A vaccination programme introduced to protect babies and older adults against a dangerous respiratory disease has cut ...

The success of an ongoing pilot programme offering RSV vaccination to newborn infants provides hope in tackling the ...

In light of Pope Francis’ pneumonia diagnosis, Dr. Leana Wen explains why older adults are especially at risk for serious ...

The respiratory syncytial virus (RSV) vaccine triggered strong immune responses among people aged 60 years and older during ...

The NHS has begun inviting older people in Oxfordshire to receive their respiratory syncytial virus (RSV) vaccine.

In adults aged 50 years and older, coadministration of respiratory syncytial virus vaccine mRNA-1345 plus seasonal influenza or COVID-19 vaccines was safe and noninferior to individual vaccine ...

Respiratory syncytial virus is a common, highly contagious illness that often causes mild upper respiratory symptoms, akin to a cold. In babies, particularly those with tiny airways, RSV can cause the ...

Robust immune responses were observed among healthy and high-risk younger adults who received the Ad26/protein RSV preF vaccine.